Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Camilla Dalby Hansen,Eva-Marie Gram-Kampmann,Johanne Kragh Hansen,Mie Balle Hugger,Bjørn Stæhr Madsen,Jane Møller Jensen,Sara Olesen,Nikolaj Torp,Ditlev Nytoft Rasmussen,Maria Kjærgaard,Stine Johansen,Katrine Prier Lindvig,Peter Andersen,Katrine Holtz Thorhauge,Jan Christian Brønd,Pernille Hermann,Henning Beck-Nielsen,Sönke Detlefsen,Torben Hansen,Kurt Højlund,Maja Sofie Thiele,Mads Israelsen,Aleksander Krag
DOI: https://doi.org/10.7326/M22-1787
IF: 39.2
2022-12-13
Annals of Internal Medicine
Abstract:It remains unclear if a low-carbohydrate, high-fat (LCHF) diet is a possible treatment strategy for type 2 diabetes mellitus (T2DM), and the effect on nonalcoholic fatty liver disease (NAFLD) has not been investigated. To investigate the effect of a calorie-unrestricted LCHF diet, with no intention of weight loss, on T2DM and NAFLD compared with a high-carbohydrate, low-fat (HCLF) diet. 6-month randomized controlled trial with a 3-month follow-up. (ClinicalTrials.gov: NCT03068078) Odense University Hospital in Denmark from November 2016 until June 2020. 165 participants with T2DM. Two calorie-unrestricted diets: LCHF diet with 50 to 60 energy percent (E%) fat, less than 20E% carbohydrates, and 25E% to 30E% proteins and HCLF diet with 50E% to 60E% carbohydrates, 20E% to 30E% fats, and 20E% to 25E% proteins. Glycemic control, serum lipid levels, metabolic markers, and liver biopsies to assess NAFLD. The mean age was 56 years (SD, 10), and 58% were women. Compared with the HCLF diet, participants on the LCHF diet had greater improvements in hemoglobin A 1c (mean difference in change, −6.1 mmol/mol [95% CI, −9.2 to −3.0 mmol/mol] or −0.59% [CI, −0.87% to −0.30%]) and lost more weight (mean difference in change, −3.8 kg [CI, −6.2 to −1.4 kg]). Both groups had higher high-density lipoprotein cholesterol and lower triglycerides at 6 months. Changes in low-density lipoprotein cholesterol were less favorable in the LCHF diet group than in the HCLF diet group (mean difference in change, 0.37 mmol/L [CI, 0.17 to 0.58 mmol/L] or 14.3 mg/dL [CI, 6.6 to 22.4 mg/dL]). No statistically significant between-group changes were detected in the assessment of NAFLD. Changes were not sustained at the 9-month follow-up. Open-label trial, self-reported adherence, unintended weight loss, and lack of adjustment for multiple comparisons. Persons with T2DM on a 6-month, calorie-unrestricted, LCHF diet had greater clinically meaningful improvements in glycemic control and weight compared with those on an HCLF diet, but the changes were not sustained 3 months after intervention. Novo Nordisk Foundation.
medicine, general & internal